SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients
Authors
Keywords
-
Journal
HYPERTENSION
Volume 79, Issue 8, Pages 1633-1643
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-07-14
DOI
10.1161/hypertensionaha.122.19586
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlation of physical and cognitive impairment in diabetic and hypertensive frail older adults
- (2022) Pasquale Mone et al. Cardiovascular Diabetology
- Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment
- (2022) Vismitha Rajeev et al. Theranostics
- Spatiotemporal Dynamics of Cerebral Vascular Permeability in Type 2 Diabetes-Related Cerebral Microangiopathy
- (2022) Ying-Chen Chen et al. Frontiers in Endocrinology
- Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors and Combined SGLT1/2 Inhibitors on Cardiovascular, Metabolic, Renal, and Safety Outcomes in Patients with Diabetes: A Network Meta-Analysis of 111 Randomized Controlled Trials
- (2022) Yao Neng Teo et al. American Journal of Cardiovascular Drugs
- Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry
- (2022) Pasquale Paolisso et al. Cardiovascular Diabetology
- Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction
- (2022) Pasquale Mone et al. DIABETES CARE
- An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors
- (2022) Teresa Salvatore et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sodium Glucose Cotransporter Type 2 Inhibitors Improve Cardiorenal Outcome of Patients With Coronary Artery Disease: A Meta-Analysis
- (2022) Wen Wei et al. Frontiers in Endocrinology
- Comparative Cardiovascular Outcomes of SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Network Meta-Analysis of Randomized Controlled Trials
- (2022) Yu Jiang et al. Frontiers in Endocrinology
- Hyperglycemia and Physical Impairment in Frail Hypertensive Older Adults
- (2022) Antonella Pansini et al. Frontiers in Endocrinology
- Cardiovascular Benefits With Favorable Renal, Amputation and Hypoglycemic Outcomes of SGLT-2 Inhibitors in Type 2 Diabetes From the Asian Perspective: A Population-Based Cohort Study and Systematic Review
- (2022) Chun-Ting Yang et al. Frontiers in Endocrinology
- Frailty Test Battery Development including Physical, Socio-Psychological and Cognitive Domains for Cardiovascular Disease Patients: A Preliminary Study
- (2022) Nastasia Marinus et al. Journal of Clinical Medicine
- Resilience integrates concepts in aging research
- (2022) Daniel Promislow et al. iScience
- Inhibition of oxidative stress delays senescence and augments functional capacity of endothelial progenitor cells
- (2022) Rais Reskiawan A. Kadir et al. BRAIN RESEARCH
- Renoprotective effect of empagliflozin in cafeteria diet-induced insulin resistance in rats: Modulation of HMGB-1/TLR-4/NF-κB axis
- (2022) Dina E. Al-Wakeel et al. LIFE SCIENCES
- Blood pressure, antihypertensive drugs, and incident frailty: The Multidomain Alzheimer Preventive Trial (MAPT)
- (2022) Laure Rouch et al. MATURITAS
- Sodium Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Hospitalization in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2021) Ailing Zhang et al. Frontiers in Endocrinology
- Increase of blood-brain barrier leakage is related to cognitive decline in vascular mild cognitive impairment
- (2021) Man Li et al. BMC Neurology
- Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes
- (2021) V. Sciannameo et al. Cardiovascular Diabetology
- Cardiovascular Protection With Sodium-Glucose Cotransporter-2 Inhibitors and Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease
- (2021) Pantelis Sarafidis et al. HYPERTENSION
- The Impaired Bioenergetics of Diabetic Cardiac Microvascular Endothelial Cells
- (2021) Haitao Zhang et al. Frontiers in Endocrinology
- Diabetes and Thrombosis: A Central Role for Vascular Oxidative Stress
- (2021) Aishwarya R. Vaidya et al. Antioxidants
- Hyperglycemia Drives Stent Restenosis in STEMI Patients
- (2021) Pasquale Mone et al. DIABETES CARE
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blood–Brain Barrier Breakdown: An Emerging Biomarker of Cognitive Impairment in Normal Aging and Dementia
- (2021) Basharat Hussain et al. Frontiers in Neuroscience
- Cognitive Impairment in Frail Hypertensive Elderly Patients: Role of Hyperglycemia
- (2021) Pasquale Mone et al. Cells
- Transcriptomic Analysis of HCN-2 Cells Suggests Connection among Oxidative Stress, Senescence, and Neuron Death after SARS-CoV-2 Infection
- (2021) Andrea Valeri et al. Cells
- Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure
- (2021) R. Pietschner et al. Cardiovascular Diabetology
- Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
- (2021) Stephanie Kullmann et al. DIABETES CARE
- Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database
- (2021) Hajime Nagasu et al. DIABETES CARE
- 13. Older Adults: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- SGLT2 inhibitors: the statins of the 21st century
- (2021) Eugene Braunwald EUROPEAN HEART JOURNAL
- Systolic Blood Pressure and Mortality in Community-Dwelling Older Adults: Frailty as an Effect Modifier
- (2021) Kaj-Marko Kremer et al. HYPERTENSION
- Empagliflozin Protects against Pulmonary Ischemia/Reperfusion Injury via an ERK1/2-Dependent Mechanism
- (2021) Dou Huang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Frailty Is Associated with Oxidative Stress in Older Patients with Type 2 Diabetes
- (2021) Blanca Alabadi et al. Nutrients
- A mitochondrial root to accelerated ageing and frailty
- (2020) Luigi Ferrucci et al. Nature Reviews Endocrinology
- Molecular adaptations of the blood–brain barrier promote stress resilience vs. depression
- (2020) Katarzyna A. Dudek et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating anti-geronic factors from heterochonic parabionts promote vascular rejuvenation in aged mice: transcriptional footprint of mitochondrial protection, attenuation of oxidative stress, and rescue of endothelial function by young blood
- (2020) Tamas Kiss et al. GeroScience
- 2020 International Society of Hypertension Global Hypertension Practice Guidelines
- (2020) Thomas Unger et al. HYPERTENSION
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oxidative Stress, Telomere Shortening, and Apoptosis Associated to Sarcopenia and Frailty in Patients with Multimorbidity
- (2020) Máximo Bernabeu-Wittel et al. Journal of Clinical Medicine
- Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk
- (2020) Francesco Giorgino et al. Cardiovascular Diabetology
- 12. Older Adults: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction
- (2020) Carlos G. Santos-Gallego et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mechanisms of SGLT2 (Sodium-Glucose Transporter Type 2) Inhibition-Induced Relaxation in Arteries From Human Visceral Adipose Tissue
- (2020) Alessandro De Stefano et al. HYPERTENSION
- Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial
- (2020) Jesper Jensen et al. Lancet Diabetes & Endocrinology
- Frailty and Risk of Fractures in Patients With Type 2 Diabetes
- (2019) Guowei Li et al. DIABETES CARE
- Selective loss of cortical endothelial tight junction proteins during Alzheimer’s disease progression
- (2019) Yu Yamazaki et al. BRAIN
- Relationship between frailty and mortality, hospitalization, and cardiovascular diseases in diabetes: a systematic review and meta-analysis
- (2019) Satoshi Ida et al. Cardiovascular Diabetology
- Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial
- (2019) Subodh Verma et al. CIRCULATION
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
- (2019) Brendon L Neuen et al. Lancet Diabetes & Endocrinology
- Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet
- (2019) Liang Xu et al. BMJ Open Diabetes Research & Care
- Cardiosomal microRNAs Are Essential in Post-Infarction Myofibroblast Phenoconversion
- (2019) Marco B. Morelli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hyperglycemia-Driven Neuroinflammation Compromises BBB Leading to Memory Loss in Both Diabetes Mellitus (DM) Type 1 and Type 2 Mouse Models
- (2018) Slava Rom et al. MOLECULAR NEUROBIOLOGY
- Vascular Cognitive Impairment Linked to Brain Endothelium Inflammation in Early Stages of Heart Failure in Mice
- (2018) Mateusz G. Adamski et al. Journal of the American Heart Association
- Oxidative stress, aging, and diseases
- (2018) Ilaria Liguori et al. Clinical Interventions in Aging
- Frailty and the endocrine system
- (2018) Andrew Clegg et al. Lancet Diabetes & Endocrinology
- Increases in circulating levels of ketone bodies and cardiovascular protection with SGLT2 inhibitors: Is low-grade inflammation the neglected component?
- (2018) Francesco Prattichizzo et al. DIABETES OBESITY & METABOLISM
- High Systolic Blood Pressure Induces Cerebral Microvascular Endothelial Dysfunction, Neurovascular Unit Damage, and Cognitive Decline in Mice
- (2018) Olivia de Montgolfier et al. HYPERTENSION
- Empagliflozin, an SGLT2 inhibitor, reduced the mortality rate after acute myocardial infarction with modification of cardiac metabolomes and anti-oxidants in diabetic rats.
- (2018) Hiroto Oshima et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia
- (2018) Feixue Wang et al. Frontiers in Aging Neuroscience
- Oxidative Stress, Inflammation, and Vascular Aging in Hypertension
- (2017) Tomasz J. Guzik et al. HYPERTENSION
- Social stress induces neurovascular pathology promoting depression
- (2017) Caroline Menard et al. NATURE NEUROSCIENCE
- Sirolimus induces depletion of intracellular calcium stores and mitochondrial dysfunction in pancreatic beta cells
- (2017) Angela Lombardi et al. Scientific Reports
- Redox control of senescence and age-related disease
- (2017) Akshaya Chandrasekaran et al. Redox Biology
- Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes
- (2016) Andrew O. Odegaard et al. Cardiovascular Diabetology
- 2. Classification and Diagnosis of Diabetes
- (2016) DIABETES CARE
- Glucose Levels and Risk of Frailty
- (2016) Oleg Zaslavsky et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Hyperglycemia-Mediated Oxidative Stress Increases Pulmonary Vascular Permeability
- (2016) John S. Clemmer et al. MICROCIRCULATION
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mitochondrial calcium overload is a key determinant in heart failure
- (2015) Gaetano Santulli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tyr Phosphatase-Mediated P-ERK Inhibition Suppresses Senescence in EIA + v-raf Transformed Cells, Which, Paradoxically, Are Apoptosis-Protected in a MEK-Dependent Manner
- (2015) Stefania De Vitis et al. NEOPLASIA
- Functional Role of Calstabin2 in Age-related Cardiac Alterations
- (2014) Qi Yuan et al. Scientific Reports
- Frailty Assessment in the Cardiovascular Care of Older Adults
- (2013) Jonathan Afilalo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Higher glucose levels associated with lower memory and reduced hippocampal microstructure
- (2013) L. Kerti et al. NEUROLOGY
- A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials
- (2011) Giovanni Musso et al. ANNALS OF MEDICINE
- Regulation of Endothelial Function by Mitochondrial Reactive Oxygen Species
- (2011) Michael E. Widlansky et al. ANTIOXIDANTS & REDOX SIGNALING
- Altered Mitochondrial Dynamics Contributes to Endothelial Dysfunction in Diabetes Mellitus
- (2011) Sherene M. Shenouda et al. CIRCULATION
- Correlates of Quality of Life in Older Adults With Diabetes
- (2011) Neda Laiteerapong et al. DIABETES CARE
- Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function
- (2011) K. Suzuki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started